Recombinant Proteins

p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax
BID

FABP4 Human

Fatty Acid Binding Protein 4 Human

The Human FABP4 produced from Human Adipose Tissue has a molecular mass of 14.587kDa (calculated without glycosylation) containing 131 amino acid residues.
Shipped with Ice Packs
Cat. No.
BT6778
Source
Human Adipose Tissue.
Appearance
Filtered White lyophilized (freeze-dried) powder.

FABP4 Human, His

Fatty Acid Binding Protein 4 Human Recombinant, His Tag

FABP4 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 132 amino acids and having a molecular mass of 18 kDa. FABP4 is fused to His tag at N-terminus and purified by standard chromatography techniques.
Shipped with Ice Packs
Cat. No.
BT6870
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless liquid formulation.

FABP4 Protein

Fatty Acid Binding Protein 4 Human Recombinant

14.7kDa protein containing 132 amino acid residues.
Shipped with Ice Packs
Cat. No.
BT6944
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

FABP5 Human

Epidermal Fatty Acid Binding Protein Human Recombinant

Recombinant Human Epidermal Fatty Acid Binding Protein (FABP-5) is a monomeric, non-glycosylated, polypeptide chain containing 135 amino acids and having a total molecular mass of 15200 Daltons.

Shipped with Ice Packs
Cat. No.
BT7038
Source
Escherichia Coli.
Appearance
Sterile Filtered lyophilized (freeze-dried) powder.

FABP5 Human, His

Fatty Acid Binding Protein 5 Human Recombinant, His Tag

FABP5 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 135 amino acids and having a molecular mass of 19.66kDa. FABP5 is fused to His tag at N-terminus and purified by standard chromatography techniques.
Shipped with Ice Packs
Cat. No.
BT7125
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless liquid formulation.

FABP6 Human

Fatty Acid Binding Protein-6 Human Recombinant

FABP6 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 128 amino acids and having a molecular mass of 14 kDa.
Shipped with Ice Packs
Cat. No.
BT7215
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.

FABP6 Human, His

Fatty Acid Binding Protein 6 Human Recombinant, His Tag

FABP6 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 128 amino acids and having a molecular mass of 18 kDa. FABP6 is fused to His tag at N-terminus and purified by standard chromatography techniques.
Shipped with Ice Packs
Cat. No.
BT7305
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless liquid formulation.

FABP7 Human

Fatty Acid Binding Protein-7 Human Recombinant

FABP7 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 132 amino acids and having a molecular mass of 14 kDa.
Shipped with Ice Packs
Cat. No.
BT7369
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.

FABP7 Human, His

Fatty Acid Binding Protein-7 Human Recombinant, His Tag

FABP7 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 132 amino acids and having a molecular mass of 19.39kDa. FABP7 is fused to His-Tag at N-terminus and purified by standard chromatography techniques.
Shipped with Ice Packs
Cat. No.
BT7444
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.

FABP9 Human

Fatty Acid Binding Protein-9 Human Recombinant

FABP9 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 156 amino acids (1-132 a.a) and having a molecular mass of 17.6kDa.
FABP9 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT7521
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.
Definition and Classification

Fatty acid-binding proteins (FABPs) are a family of low-molecular-weight intracellular proteins that bind to hydrophobic ligands, primarily fatty acids. These proteins play a crucial role in the transport and metabolism of fatty acids within cells . FABPs are classified into several types based on their tissue-specific expression, including liver (L-FABP), intestine (I-FABP), heart (H-FABP), adipocyte (A-FABP), epidermal (E-FABP), ileal (Il-FABP), brain (B-FABP), myelin (M-FABP), and testis (T-FABP) .

Biological Properties

FABPs are small, structurally conserved cytosolic proteins with a water-filled interior-binding pocket surrounded by ten anti-parallel beta sheets, forming a beta barrel . They are ubiquitously expressed in tissues that are highly active in fatty acid metabolism, such as the liver, intestine, heart, adipose tissue, and brain . The expression patterns of FABPs are tissue-specific, with each type predominantly expressed in certain tissues but not exclusively limited to them .

Biological Functions

The primary function of FABPs is to bind fatty acids and facilitate their transport within cells . They enhance the solubility of hydrophobic fatty acids, allowing their efficient transport within the aqueous cytoplasm . FABPs also play a role in immune responses and pathogen recognition by modulating lipid-mediated signaling pathways . They are involved in various cellular processes, including signal transduction, lipid droplet storage, trafficking, membrane synthesis, and lipid-mediated transcriptional regulation .

Modes of Action

FABPs function as cytoplasmic lipid chaperones, facilitating fatty acid solubilization, trafficking, and metabolism . They interact with various membrane and intracellular proteins, such as peroxisome proliferator-activated receptors (PPARs) and hormone-sensitive lipase (HSL), to regulate tissue and cellular-specific lipid responses . By transporting fatty acids to the nucleus, FABPs can modulate the activity of nuclear receptors involved in transcriptional regulation .

Regulatory Mechanisms

The expression and activity of FABPs are regulated by various mechanisms, including transcriptional regulation and post-translational modifications . For example, the expression of FABP1 is regulated by PPAR isoforms, with PPARα and PPARβ agonists inhibiting its expression, while PPARγ agonists increase its expression . Post-translational modifications, such as phosphorylation, can also influence the activity and function of FABPs .

Applications

FABPs have several applications in biomedical research, diagnostic tools, and therapeutic strategies . They serve as biomarkers for disease diagnosis and prognosis, particularly in cardiovascular diseases where elevated levels of heart-type FABP (H-FABP) in blood plasma are associated with acute myocardial infarction . FABPs are also being explored as potential therapeutic targets for metabolic disorders, cancer, and neurological diseases .

Role in the Life Cycle

Throughout the life cycle, FABPs play a critical role in development, aging, and disease . They are involved in the regulation of lipid metabolism and energy homeostasis, which are essential for growth and development . During aging, the levels of FABPs decline, which may contribute to age-associated decline in synaptic activity and other metabolic processes . In disease states, such as metabolic syndrome and cancer, FABPs are often dysregulated, highlighting their importance in maintaining cellular homeostasis .

© Copyright 2024 Thebiotek. All Rights Reserved.